BAYRY News and Press, Bayer AG ADR From 05/19/23

2023-05-19 05:13:23 ET The European Medicines Agency (EMA) has accepted and validated Swedish Orphan Biovitrum's (Sobi) ( OTCPK:BIOVF ) application seeking approval of hemophilia A therapy efanesoctocog alfa. Sobi and Sanofi ( NASDAQ: SNY ) have a collabo...

2023-05-18 04:47:29 ET China's National Medical Products Administration (NMPA) approved the expanded use of Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) Kerendia to include earlier stages of chronic kidney disease (CKD) linked with type 2 diabetes (T2D) and reduce pat...

2023-05-17 06:07:04 ET Precision oncology company Boundless Bio closed a $100M Series C financing co-led by Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) investment arm Leaps by Bayer, and RA Capital Management. There was also participation from additional new investors, S...

2023-05-16 12:36:04 ET Summary Capitalizing on the promise of focused oligopoly-level businesses, in 2019, we bought Corteva stock when DowDuPont broke into three companies. Bayer appears to have bottomed out as its incoming CEO considers spinning off its agriscience giant focused...

2023-05-16 06:24:25 ET The U.S. Food and Drug Administration (FDA) granted fast track designation to Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) asundexian as potential therapy to prevent stroke and systemic embolism in people with atrial fibrillation (AF). Asundexian (BAY243...

2023-05-12 07:25:46 ET The erectile dysfunction market is expected to grow at a CAGR of 7.1% from 2021 to 2028. The growth of the market is attributed to […] For further details see: Erectile Dysfunction Swells as Growth Market for Investors (PFE, MGRX, LLY, CELZ, HIMS, TEVA, BAYRY)

2023-05-11 11:40:25 ET Bayer AG (BAYZF) Q1 2023 Earnings Conference Call May 11, 2023, 8:00 AM ET Company Participants Oliver Maier - Head of Investor Relations Werner Baumann - Chief Executive Officer Stefan Oelrich - Head, Pharmaceuticals Division Rodrigo S...

2023-05-11 05:22:44 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) said it saw a slow start to year as Q1 sales in Crop Science and Pharmaceuticals both saw a decline, while Consumer Health segment grew. CEO Werner Baumann said that for the remainder of the year Bayer sees ...

2023-05-10 07:51:51 ET Bayer ( OTCPK:BAYRY ) ( OTCPK:BAYZF ) and Bicycle Therapeutics ( NASDAQ: BCYC ) are collaborating to develop, make and sell Bicycle radioconjugates for multiple cancer targets. Bicycle will receive $45M upfront and potential development and ...

2023-05-10 06:21:20 ET Alvotech ( NASDAQ: ALVO ) signed an exclusive agreement with Polifarma Ilac San. ve tic. for the commercialization in Turkey of AVT06, a proposed biosimilar to Regeneron Pharmaceuticals ( REGN ) and Bayer's ( OTCPK:BAYRY ) ( OTCPK:BAYZF ...